An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infectionKevin P. Egan, Harvey M. Friedman, Lauren M. Hook et al.|PLoS Pathogens|2020Cited by 65
Vaccines to prevent genital herpesKevin P. Egan, Harvey M. Friedman, Lauren M. Hook et al.|Translational research|2020Cited by 33
A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1Kevin P. Egan, Harvey M. Friedman, Drew Weissman et al.|Viruses|2023Cited by 28
Antibodies to Crucial Epitopes on HSV-2 Glycoprotein D as a Guide to Dosing an mRNA Genital Herpes VaccineLauren M. Hook, Harvey M. Friedman, Sita Awasthi et al.|Viruses|2022Cited by 17
Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infectionKevin P. Egan, Sita Awasthi, Lauren M. Hook et al.|Human Vaccines & Immunotherapeutics|2020Cited by 15